Biology:UroVaxom
From HandWiki
UroVaxom (developmental code names OM-89, OM-8980) is a vaccine against urinary tract infections (UTIs).[1][2][3] It is an extract of 18 strains of killed Escherichia coli administered as an oral tablet once daily for 3 months.[1][4][2] The vaccine is marketed for use in the prevention of recurrent UTIs in some European countries.[1][2] It was also being studied for treatment of prostatitis but was discontinued.[1] UroVaxom was initially developed in the 1980s.[5]
See also
- UTI vaccine
References
- ↑ 1.0 1.1 1.2 1.3 "OM 8980". 16 August 2022. https://adisinsight.springer.com/drugs/800000983.
- ↑ 2.0 2.1 2.2 "Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections". Microbiology Spectrum 4 (1). February 2016. doi:10.1128/microbiolspec.UTI-0013-2012. PMID 26999391.
- ↑ "Role of Vaccines for Recurrent Urinary Tract Infections: A Systematic Review". European Urology Focus 6 (3): 593–604. May 2020. doi:10.1016/j.euf.2019.11.002. PMID 31806578.
- ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedHughesJuliebø-JonesSaada2021 - ↑ "The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli". Clinical Microbiology and Infection 24 (10): 1046–1050. October 2018. doi:10.1016/j.cmi.2018.05.009. PMID 29803843.
 |  |
